Under the agreement, RTI will process cervical and lumbar spinal grafts from designs developed by Aesculap Implant Systems.
Brian Hutchison, chairman and CEO of RTI, said: “We are pleased to work with Aesculap Implant Systems to deliver more sterilized spinal implants to surgeons. Through our agreement, we will be able to help even more patients with biologic solutions in spinal surgeries.”